Philips is a global healthcare company focused on improving health and well-being through innovative technology. Their offerings include monitoring and analytics systems that support healthcare providers in delivering personalized treatment and patient care.
Over the past decade we have transformed into a focused leader in health technology.
At Philips, our purpose is to improve people’s health and well-being through meaningful innovation. We aim to improve 2.5 billion lives per year by 2030, including 400 million in underserved communities.
We see healthcare as a connected whole. Helping people to live healthily and prevent disease. Giving clinicians the tools they need to make a precision diagnosis and deliver personalized treatment. Aiding the patient's recovery at home in the community. All supported by a seamless flow of data.
As a technology company, we – and our brand licensees – innovate for people with one consistent belief: there’s always a way to make life better.
Visit our website: http://www.philips.com/
Follow our social media house rules https://www.philips.com/a-w/about-philips/social-media.html
Amsterdam (Netherlands) 1891 10000+ $4.23B IPO, January 13, 1978 1 year ago
Masimo Corporation specializes in developing non-invasive patient monitoring technologies and solutions, including advanced sensors and devices for tracking various physiological parameters. Their products also encompass remote monitoring and management solutions aimed at enhancing patient care and safety.
Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. Our mission is to improve life, improve patient outcomes, reduce the cost of care, and take noninvasive monitoring to new sites and applications. Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown to outperform other pulse oximetry technologies in over 100 independent and objective studies, which can be found at www.masimo.com/evidence/featured-studies/feature. Masimo SET® is estimated to be used on more than 200 million patients around the world each year and is the primary pulse oximetry at all 10 top U.S. hospitals as ranked in the 2025 Newsweek World’s Best Hospitals listing. Additional information about Masimo and its products may be found at www.masimo.com.
Irvine (United States) 1989 1001 - 5000 $754.95M Acquired, February 2026 1 year ago
Health Recovery Solutions provides a telehealth and remote monitoring platform that enhances patient engagement and reduces hospital readmissions through real-time monitoring and education. Their solutions are designed to support various healthcare settings, improving clinical outcomes and patient satisfaction.
HRS is the leading healthcare technology company transforming quality care at home for the betterment of patients. We pair best-in-class clinical expertise, logistics, and analysis with the industry's most advanced remote care technology platform. Our digital tools and proven experience enable clinical decision-making earlier in the patient journey which, ultimately, improves patient and provider satisfaction while reducing costs and administrative burden for clinicians, hospitals, payors, and other healthcare organizations.
To learn more about Health Recovery Solutions, visit healthrecoverysolutions.com.
Hoboken (United States) 2012 51 - 200 $87.07M Series C, $70.00M, March 9, 2021 1 year ago
Accuhealth is a healthcare technology firm that specializes in remote patient monitoring, providing real-time access to vital information for physicians to enhance patient care. Their platform aims to improve health outcomes and patient satisfaction while reducing healthcare costs.
Accuhealth is a Healthcare Technology company. Having created the first Healthcare Operations Center for remote patient monitoring, Accuhealth improves primary physician care within the clinical setting and the home. With access to real-time vital information, physicians improve outcomes, increase patient satisfaction, and reduces costs.
Mcallen (United States) 2018 11 - 50 Private Equity, April 16, 2024 1 year ago
HealthSnap offers a comprehensive platform for managing chronic diseases through remote monitoring and care coordination, utilizing real-time data from connected devices to enhance patient outcomes. Their services include automated care management and integration with electronic health records, making it easier for healthcare providers to deliver proactive care.
HealthSnap is an integrated virtual care management platform that helps healthcare organizations improve patient outcomes, reduce utilization, and diversify revenue streams. From chronic disease-agnostic Remote Patient Monitoring (RPM), Chronic Care Management (CCM), and Principal Care Management (PCM) to AI-guided care coordination, virtual care delivery, patented billing tools, population analytics – and so much more, HealthSnap is the simplest way to manage chronic conditions remotely.
HealthSnap partners with 150+ health systems and provider organizations across 33 states and has remotely monitored and managed over 100,000 patients.
Miami (United States) 2015 201 - 500 $46.60M Series B, $25.00M, February 21, 2024 1 year ago
Carevive Systems specializes in personalized cancer care plans and utilizes remote symptom monitoring through electronic patient-reported outcomes (ePROs) to enhance patient engagement and improve clinical outcomes. Their platform integrates with existing EHR systems to provide real-time data and support for oncology practices.
Carevive Systems, founded in 2013, is an oncology-centered health technology company committed to understanding and improving the patient experience. Our platform enables providers to monitor patient symptoms remotely using electronic patient-reported outcomes (ePROs) and to provide timely interventions that improve survival outcomes and patient quality of life. The use of Carevive in the cancer clinic unlocks critical data on the real-world patient experience. Carevive leverages these data to continuously improve patient care and advance cancer drug development.
Miami (United States) 2013 11 - 50 $40.16M Acquired, June 2024 1 year ago
Medsensio effectively adopts remote monitoring technologies, advances clinical trials, and identifies digital biomarkers through its comprehensive platform.
Medsensio brings in AI into remote care.
We turn health data into actionable points and enable delivering predictive, personalized digital care services to improve the lives of chronic lung and heart patients.
Tromsø (Norway) 2017 1 - 10 NA 1 year ago
Empatica develops AI-enabled wearables and a health monitoring platform that continuously collects physiological data, providing real-time insights for patients and researchers. Their technology is designed for clinical trials and remote health monitoring, utilizing validated digital biomarkers for various health conditions.
Empatica is a full-stack digital health company and an MIT spin-off, with offices in Boston (MA), Milan (Italy), and Seoul (South Korea). We specialize in the development, production, and deployment of medical-grade wearables and digital biomarkers, powered by an AI-driven platform designed for continuous health monitoring and the early detection of medical conditions.
The FDA-cleared Empatica Health Monitoring Platform consists of the medical-grade EmbracePlus and EmbraceMini wearables and the world’s largest selection of validated digital measures, enabling thousands of institutional partners to remotely collect patient health data, in trials and studies on sleep, stress, epilepsy, and more.
Empatica’s Embrace wearable was the world’s first FDA-cleared smartwatch in neurology to detect epileptic seizures. In 2024, we launched its successor, EpiMonitor, with all of the most loved features of Embrace and even more. EpiMonitor is an all-in-one wearable and smartphone application solution for detecting possible generalized tonic-clonic seizures, alerting caregivers during emergencies, and monitoring epilepsy. It is the only FDA-cleared wrist-worn wearable and app combination for epilepsy monitoring in the US.
Cambridge (United States) 2011 51 - 200 $35.62M Series B, $25.95M, August 2, 2022 1 year ago
ActiGraph provides wearable devices and software solutions for monitoring physical activity, sleep, and mobility, primarily for research and clinical trials. Their technology supports data collection and analysis to enhance clinical outcomes and patient care.
Avec plus de vingt ans d'expertise dans la collecte de données à distance, ActiGraph est le principal fournisseur de capteurs de mouvement portables de qualité médicale pour la communauté scientifique mondiale. Les biocapteurs agréés par la FDA et l'écosystème technologique flexible d'ActiGraph fournissent des données numériques continues de haute qualité, permettant de recueillir des informations précieuses sur les comportements humain liés à l'activité, au sommeil et à la mobilité. Apparaissant dans plus de 17 000 publications scientifiques publiés à ce jour, ActiGraph est le partenaire technologique portable le plus expérimenté, le plus compétent et le plus fiable du secteur.
Pensacola (United States) 2004 11 - 50 Acquired, May 2020 1 year ago
Ixico is a U.K.-based company specializing in clinical trial services, particularly in neuroimaging and digital biomarker solutions for neurological disorders. They provide comprehensive support for drug development analytics and have a global network of imaging centers for efficient trial execution.
IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.
The IXICO Platform deploys the very latest disease-specific algorithms to create reliable clinical data and precision insights that can help accelerate R&D decision making, de-risk clinical research and maximise the potential of drug development programmes.
London (United Kingdom) 1995 51 - 200 $17.84M IPO, October 15, 2013 1 year ago
Alacrity Care effectively employs remote monitoring technologies and identifies digital biomarkers to enhance patient care and advance clinical trials.
Alacrity develops technology that can enable safe deployment of curative treatment to every cancer patient. We build novel data collection tools and AI-enabled diagnostics to predict side effects before patients present with symptoms.
Alacrity — Precision Management for Precision Medicine.
Los Angeles (United States) 2012 1 - 10 NA 1 year ago
Evidation develops a health data analytics platform that collects and analyzes everyday behavior data to generate insights about health and diseases. They focus on empowering individuals to participate in health research and improve health outcomes through real-world data.
Evidation creates new ways to measure and improve health in everyday life—making proactive, personalized, and truly human-centered healthcare possible. By connecting directly with millions of individuals, Evidation harnesses real-world data to deeply understand health experiences, rapidly and at scale. Evidation’s privacy-centric digital health measurement and engagement platform uses data science and machine learning to translate these everyday insights into high-impact health guidance, treatments, and tools. Founded in 2012, Evidation is headquartered in California with employees working around the globe.
San Mateo (United States) 2012 51 - 200 $259.00M Series E, $153.00M, March 22, 2021 1 year ago
Coviu is a telehealth platform that enhances virtual consultations with AI-backed clinical tools and a variety of integrated applications. It offers features like remote patient monitoring and a marketplace of tools tailored for diverse healthcare specialties.
Coviu is a global telehealth software built for healthcare professionals and organizations with integrated assessments and resources optimized for remote delivery. Our software is browser-based, meaning no downloads are required and access to your digital practice is just a click away.
As healthcare professionals seek to unlock greater work/life flexibility, cost savings, better healthcare outcomes, and expand their clinical reach with telehealth, Coviu enables this through:
- Simple and Secure Video Conferencing
- A Rich Library of Interactive Tools, Resources, and Teleassessments including from providers Pearson, Boom Learning, eLr, and more!
- Phone Telehealth
- Group Telehealth Rooms
- Remote Patient Monitoring
- Privacy and Security (HIPAA, FERPA and ISO 27001 compliant)
Our ultimate goal is to be a catalyst for life-changing online care anywhere.
https://www.coviu.com
South Brisbane (Australia) 2015 51 - 200 $7.32M Series A, $6.00M, December 7, 2020 1 year ago
Koneksa Health excels in remote patient monitoring and digital biomarker development, enhancing clinical trials and disease tracking.
Koneksa transforms complex multimodal measures into actionable clinical insights. Its platform unifies digital biomarkers, wearable sensor data, patient-reported outcomes, and clinical measures to deliver a deeper view of disease, treatment response, and patient well-being. With a remote-first, patient-centric approach, Koneksa reduces site burden, improves accessibility, and captures continuous real-world evidence. By accelerating trial timelines, enhancing decision-making, and supporting participant retention, Koneksa advances therapeutic innovation from early discovery through post-market studies.
New York (United States) 2015 51 - 200 $70.65M Grant, August 8, 2022 1 year ago
TytoCare is a mobile-health platform that enables self-physical examinations and remote diagnoses through its telehealth products. Their solutions include a modular examination tool and a cloud-based platform for sharing exam data and conducting live video consultations.
TytoCare works with leading health plans and providers to roll out Home Smart Clinic solutions that enable accessible, high-quality primary care from home, with no compromises. The Home Smart Clinic solutions include remote physical exams that work across primary care modalities and can be tailored to any cohort or population. Together with Tyto Insights™, our AI-powered diagnostics and guidance, and Tyto Engagement Labs™, our member journeys and engagement frameworks, Home Smart Clinic solutions ensure more equitable access to care across the globe and enable healthcare organizations to meet their KPIs. TytoCare’s solutions resolve 59% more conditions than audio and video telehealth solutions and reduce the cost of care by 10-20%. Co-founded by Dedi Gilad and Ofer Tzadik in 2012, TytoCare has FDA and CE clearances and partners with over 180 major health systems, health plans, and strategic partners in the U.S., Europe, Asia, Latin America, and Israel.
New York (United States) 2011 51 - 200 $205.70M Series E, $49.00M, August 3, 2023 1 year ago
Altoida is pioneering a platform for assessing brain health using augmented reality and machine learning, focusing on early detection of cognitive impairments. Their technology aims to provide objective evaluations of neurological conditions, enhancing clinical trial outcomes and monitoring disease progression.
Altoida is a pioneer in developing digital biomarkers of neurological conditions, including Alzheimer’s Disease, using augmented reality and machine learning. Our technology platform is designed to enable an objective evaluation of an individual’s cognitive health and function, which may potentially allow for faster and more sensitive monitoring of disease progression and treatment response. Altoida is a privately-held, venture-backed, commercial stage company and our proprietary evidence-based platform is founded on more than 20 years of scientific research and published in multiple peer-reviewed papers including Nature Digital Medicine.
Washington (United States) 2016 11 - 50 $24.75M Series A, $14.00M, March 30, 2022 1 year ago
Verily is a health technology company that focuses on research, care, and health financing, utilizing technology and data science to enhance personalized healthcare. They develop tools and products aimed at improving health outcomes and accelerating evidence generation in the healthcare sector.
Verily is an Alphabet data platform and AI company purpose-built for precision health. We combine deep clinical, regulatory, and technological expertise to provide our customers with patient-centric solutions that make healthcare more personal and precise. Verily solutions are designed to make healthcare data AI-ready and fit for purpose across care, research, and public health. For more information about Verily please visit: verily.com.
Verily is hiring! Check out what's available globally at verily.com/careers.
South San Francisco (United States) 2015 1001 - 5000 $3.81B Private Equity, $300.00M, March 19, 2026 1 year ago
VivoSense excels in remote patient monitoring and the development of digital biomarkers, significantly advancing clinical trials and healthcare research.
Our Solutions. Your Value.
We are your complete Wearable Sensor CRO
We provide meaningful insights by selecting devices, vetting and managing device vendors, and overseeing all aspects of data collection, cleaning, and analysis.
We turn high-volume, complex sensor data into structured, meaningful results. Our proprietary DHT platform is the compliant and auditable solution for use in your clinical trials.
The VivoSense clinical operations and data science teams have decades of experience overseeing all digital health technology implementation and sensor data analysis.
Newport Coast (United States) 2010 11 - 50 $27.00M Grant, January 9, 2023 1 year ago
Orikami excels in remote monitoring technologies, advancing clinical trials, and developing digital biomarkers for personalized healthcare.
Orikami is a Dutch MedTech organization specialized in applied data science and development and implementation of digital biomarkers to enable personalized healthcare for people with chronic diseases. With a team of data scientists and researchers we are on a mission to improve 100 million lives before 2030 by access to personalized healthcare.
We believe health data is underutilized. We use real world patient data to enable personalized healthcare paths for our clients to improve outcomes, quality of life and affordable healthcare. Therefore we develop digital biomarkers.
Digital biomarkers are defined as objective, quantifiable physiological and behavioural data that are collected and measured by means of digital devices such as portables, wearables, implantables or digestibles. The collected data is typically used to monitor, explain, influence and/or predict health-related outcomes.
Advanced analytics, machine learning, artificial intelligence: developments in the field of decision-making based on data analysis are moving fast. Data in healthcare matters!
Nijmegen (Netherlands) 2011 11 - 50 $659.06K Seed, $659.06K, October 9, 2019 1 year ago
MyHealios effectively employs remote monitoring technologies and focuses on the identification and validation of digital biomarkers to enhance clinical trials and patient care.
Combining consumer devices' sensor data with AI, Dreams generates Digital Biomarkers to improve MS diagnosis and treatment monitoring.
dreaMS is a Software as Medical Device (CE-Mark) designed to assess neurological functions using novel Digital Biomarkers focused in the following domains: Movement, Balance, Dexterity and Vision
dreaMS is the product of a collaboration between Healios and RC2NB, a neuroscience research foundation connected to Universitätsspital Basel led by Professor L Kappos.
Flemington, New Jersey (United States) 2011 11 - 50 NA 1 year ago
nference develops advanced technologies that leverage real-world data for remote monitoring, optimizing clinical trials, and identifying digital biomarkers.
Predible Health is an Artificial Intelligence platform in Radiology, tailored for Specialists.LungIQ is designed from the ground-up to deliver the most accurate and quantitative reports for referring pulmonologists. Built using deep learning technology trained on millions of CT images
Bangalore (India) 2016 11 - 50 Acquired, May 2022 1 year ago
Circadic effectively utilizes remote monitoring technologies to advance clinical trials and identify digital biomarkers, contributing to the development of digital health solutions.
United Kingdom 1 - 10 NA 1 year ago
Current Health effectively adopts remote monitoring technologies, advances clinical trials, and identifies digital biomarkers, making it a strong fit for the specified requirements.
Current Health provides the clinical and operational infrastructure that makes high-cost therapies and complex care safe, scalable, and accessible in community and home settings
Boston (United States) 2015 51 - 200 $92.72M Acquired, October 2021 1 year ago
Indivi effectively utilizes remote monitoring technologies to identify and validate digital biomarkers, advancing clinical trials in neuroscience.
Indivi is a TechBio company developing multi-modal deep phenotyping technologies and derived decision-making biomarkers as drug development tools for neurological diseases for instance in the form of sensor-derived measurements generated from smartphone-based assessments of cognition and motion.
Indivi is committed to developing future-proof and transformative digital endpoints as deep phenotyping instruments to accelerate and de-risk drug development in neurodegenerative disorders such as Parkinson’s disease, multiple sclerosis, Alzheimer’s disease and related dementias.
Indivi is nurturing a unique symbiotic intersection between expert in-house knowledge and experience in clinical development, data science, signal processing engineering, and advanced analytics including computational intelligence.
Through end-to-end collaborative endeavours with biopharmaceutical companies, Indivi is poised to continue its growth to improve the probability of technical and regulatory success in neuroscience drug development.
Basel (Switzerland) 2012 51 - 200 $23.00M Venture - Series Unknown, $18.80M, November 12, 2025 1 year ago
The company excels in remote monitoring and digital biomarker identification, supporting clinical trials and advancing digital health technologies.
Developer of digital biomarker sensors based in Washington, Virginia. The company offers raw sensor data, participant activity tracking, anonymization of data, data collection, clinical trials, digital biomarker datasets, and more.
Washington (United States) 2022 1 - 10 NA 1 year ago
